Novo Nordisk: Ugly Guidance, But Stock Refuses To Break Down Further [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
NVO's Wegovy pill launch shows encouraging early uptake, with supply chain issues resolved and direct channel traction building. I reckon management's conservative 2026 outlook aims to reset expectations, positioning NVO for a potential re-rating as execution potentially improves from 2027. NVO trades at 14.4x, well below historical and sector medians, while maintaining robust free cash flow and shareholder returns. For the high-conviction investor, catching the falling knife appears to be the right move on NVO now. Looking for a helping hand in the market? Members of Ultimate Growth Investing get exclusive ideas and guidance to navigate any climate. Learn More » hapabapa/iStock Editorial via Getty Images The crazy volatility in the obesity drugs market is becoming a spectacle to behold. As Novo Nordisk A/S ( NVO NONOF ) faces off against archrivals coming for its treasured market share, it is More on my IG service A Growth Investing Service To Help You Outperform I
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk CEO sees 15 million-patient opportunity in Medicare coverage for obesity drugs [CNBC]CNBC
- Novo Nordisk target cut by Deutsche Bank despite long-term optimism [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.MarketBeat
- Novo Nordisk: How Low Is Too Low? (Downgrade, Technical Analysis) [Seeking Alpha]Seeking Alpha
- Where is Novo Nordisk A/S (NVO) Headed? [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 2/10/26 - Form 6-K
- 2/9/26 - Form 6-K
- 2/5/26 - Form 6-K
- NVO's page on the SEC website